BioSyent Inc. Announces Quarterly Dividend for Shareholders
MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing commitment to provide value to its shareholders.
Details on the Dividend Declaration
Overview of the Dividend Payment
This fourth quarter dividend aligns with the previous quarter's distribution, which also stood at $0.05 per common share. This consistency resonates with BioSyent's strategy of maintaining steady returns for its investors while supporting its business objectives.
Eligibility for Qualified Dividends
This dividend is categorized as an 'eligible dividend' for Canadian income tax considerations, offering potential tax benefits to shareholders and reinforcing the company's dedication to shareholder-centric policies.
About BioSyent Inc.
BioSyent Inc. is a growth-oriented, innovative company listed on the TSX Venture Exchange under the ticker RX. The company operates in the specialty pharmaceutical sector, emphasizing in-licensing and acquisition of effective healthcare products that positively impact patients' lives. By fostering partnerships with healthcare professionals, BioSyent markets its products effectively, enhancing treatment options available to patients.
Company Financials
Currently, BioSyent has 11,262,282 common shares outstanding, reflecting its robust positioning in the market. This established base allows the company to pursue further growth and expansion opportunities within the pharmaceutical industry.
Contact Information
For inquiries regarding this announcement or further information about BioSyent Inc., interested parties can reach out to:
Mr. René C. Goehrum
President and CEO
BioSyent Inc.
Email: investors@biosyent.com
Phone: 905-206-0013
Website: www.biosyent.com
Frequently Asked Questions
What is the amount of the declared dividend by BioSyent?
The declared dividend is $0.05 per common share.
When will the dividend be payable?
The dividend will be payable on a date specified to shareholders of record.
How does the declared dividend compare with previous quarters?
The fourth quarter dividend remains the same as the previous quarter, which was also $0.05 per share.
What type of dividend has BioSyent declared?
This dividend qualifies as an 'eligible dividend' for Canadian income tax purposes.
Who can shareholders contact for more information?
Shareholders can contact Mr. René C. Goehrum, the President and CEO, for further information.
